227 related articles for article (PubMed ID: 24093166)
1. Gastrointestinal stromal tumors: risk assessment and adjuvant therapy.
Joensuu H
Hematol Oncol Clin North Am; 2013 Oct; 27(5):889-904. PubMed ID: 24093166
[TBL] [Abstract][Full Text] [Related]
2. New fronts in the adjuvant treatment of GIST.
Reichardt P; Joensuu H; Blay JY
Cancer Chemother Pharmacol; 2013 Oct; 72(4):715-23. PubMed ID: 23934322
[TBL] [Abstract][Full Text] [Related]
3. Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery.
Joensuu H; Martin-Broto J; Nishida T; Reichardt P; Schöffski P; Maki RG
Eur J Cancer; 2015 Aug; 51(12):1611-7. PubMed ID: 26022432
[TBL] [Abstract][Full Text] [Related]
4. Management of gastrointestinal stromal tumors.
Rajendra R; Pollack SM; Jones RL
Future Oncol; 2013 Feb; 9(2):193-206. PubMed ID: 23414470
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumor--background, pathology, treatment.
Eisenberg BL; Pipas JM
Hematol Oncol Clin North Am; 2012 Dec; 26(6):1239-59. PubMed ID: 23116579
[TBL] [Abstract][Full Text] [Related]
6. [A multicentre retrospective cohort study of patients with gastrointestinal stromal tumors in Shandong Province].
Ning L; Yan W; Zhang M; Gong H; Dai Y; Jiang L; Lin H; Zhang D; Zhou Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):326-30. PubMed ID: 24760638
[TBL] [Abstract][Full Text] [Related]
7. [IV. Current status and future for diagnosis and treatment of GIST].
Gakuhara A; Omori K; Masuzawa T; Nishida T
Gan To Kagaku Ryoho; 2013 Sep; 40(9):1170-4. PubMed ID: 24156131
[No Abstract] [Full Text] [Related]
8. [Treatment progress of gastrointestinal stromal tumor].
Ji X; Ji JF
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):292-6. PubMed ID: 23536354
[TBL] [Abstract][Full Text] [Related]
9. Management of localized gastrointestinal stromal tumors and adjuvant therapy with imatinib.
López RL; del Muro XG
Anticancer Drugs; 2012 Jun; 23 Suppl():S3-6. PubMed ID: 22739667
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
Li J; Dang YZ; Gao J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338
[TBL] [Abstract][Full Text] [Related]
11. The standard diagnosis, treatment, and follow-up of gastrointestinal stromal tumors based on guidelines.
Nishida T; Blay JY; Hirota S; Kitagawa Y; Kang YK
Gastric Cancer; 2016 Jan; 19(1):3-14. PubMed ID: 26276366
[TBL] [Abstract][Full Text] [Related]
12. Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A; den Bakker MA; van Geel AN; Eggermont AM; Sleijfer S; Verweij J; de Wilt JH; Verhoef C
Anticancer Drugs; 2008 Jul; 19(6):607-12. PubMed ID: 18525320
[TBL] [Abstract][Full Text] [Related]
13. A multidisciplinary approach to the diagnosis and treatment of gastrointestinal stromal tumor.
Mullady DK; Tan BR
J Clin Gastroenterol; 2013 Aug; 47(7):578-85. PubMed ID: 23751846
[TBL] [Abstract][Full Text] [Related]
14. Risk stratification models and mutational analysis: keys to optimising adjuvant therapy in patients with gastrointestinal stromal tumour.
Gronchi A
Eur J Cancer; 2013 Mar; 49(4):884-92. PubMed ID: 23206668
[TBL] [Abstract][Full Text] [Related]
15. Current management of gastrointestinal stromal tumors: Surgery, current biomarkers, mutations, and therapy.
Valsangkar N; Sehdev A; Misra S; Zimmers TA; O'Neil BH; Koniaris LG
Surgery; 2015 Nov; 158(5):1149-64. PubMed ID: 26243346
[TBL] [Abstract][Full Text] [Related]
16. Gastrointestinal stromal tumor: 5 years later.
van der Zwan SM; DeMatteo RP
Cancer; 2005 Nov; 104(9):1781-8. PubMed ID: 16136600
[TBL] [Abstract][Full Text] [Related]
17. NCCN Task Force report: gastrointestinal stromal tumor (GIST).
Demetri G; DeMatteo RP
J Natl Compr Canc Netw; 2004 Sep; 2 Suppl 3():S-25-8. PubMed ID: 23570095
[No Abstract] [Full Text] [Related]
18. Gastrointestinal stromal tumors and leiomyosarcomas.
Katz SC; DeMatteo RP
J Surg Oncol; 2008 Mar; 97(4):350-9. PubMed ID: 18286477
[TBL] [Abstract][Full Text] [Related]
19. Surveillance strategies for gastrointestinal stromal tumors.
Grotz TE; Donohue JH
J Surg Oncol; 2011 Dec; 104(8):921-7. PubMed ID: 22069177
[TBL] [Abstract][Full Text] [Related]
20. Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation.
Kang YK; Kang BW; Im SA; Lee JL; Park SR; Kang WK; Chang HM; Kim TW; Oh DY; Jung KH; Ryu MH
Cancer Chemother Pharmacol; 2013 Jan; 71(1):43-51. PubMed ID: 23053257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
